Clinical Trial Update: TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating dostarlimab (TSR-042) as maintenance therapy after chemoradiation in high-risk locally advanced cervical cancer; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Dostarlimab (dostarlimab)

Snippet

Sponsor: Grupo Español de Investigación en Cáncer de Ovario | Conditions: Cervical Cancer, Advanced Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING